A genetic variant in Rassf1a predicts outcome in mCRC...

  • Main
  • 2016 / 10
  • A genetic variant in Rassf1a predicts outcome in mCRC...
The Pharmacogenomics Journal 2016 / 10

A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials

Sebio, A, Stintzing, S, Heinemann, V, Sunakawa, Y, Zhang, W, Ichikawa, W, Tsuji, A, Takahashi, T, Parek, A, Yang, D, Cao, S, Ning, Y, Stremitzer, S, Matsusaka, S, Okazaki, S, Barzi, A, Berger, M D, Le
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Pharmacogenomics Journal
DOI:
10.1038/tpj.2016.69
Date:
October, 2016
File:
PDF, 248 KB
english, 2016
Conversion to is in progress
Conversion to is failed